1. FRI0353 Infliximab vs cyclophosphamide in pediatric takayasu's arteritis. (23rd January 2014) Authors: Stern, S.; Clemente, G.; Reiff, A.; Ramos, M.; Marzan, K.; Terreri, M.T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0496 Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis with and Without Fever. (9th June 2015) Authors: Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kummerle Deschner, J.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0065 Long-Term Safety and Effectiveness of Adalimumab in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis. (9th June 2015) Authors: Ruperto, N.; Brunner, H.; Wallace, C.; Toth, M.; Foeldvari, I.; Bohnsack, J.; Milojevic, D.; Rabinovich, E.; Vavrincova, P.; Kingsbury, D.; Marzan, K.; Quartier, P.; Minden, K.; Chalom, E.; Horneff, G.; Kuester, R.-M.; Dare, J.; Bereswill, M.; Kupper, H.; Kalabic, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0185 Efficacy of Canakinumab in Biologic NaÏVe versus Previously Biologic-Exposed SJIA Patients. (10th June 2014) Authors: Quartier, P.; Grom, A.; Ruperto, N.; Brunner, H.; Schikler, K.; Erguven, M.; Goffin, L.; Hofer, M.; Kallinich, T.; Marzan, K.; Gaillez, C.; Lheritier, K.; Abrams, K.; Martini, A.; Lovell, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0272 LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER: RESULTS FROM THE RANDOMISED PHASE 3 CLUSTER TRIAL. (2nd June 2020) Authors: Özen, S.; Ben-Chetrit, E.; Foeldvari, I.; Amarilyo, G.; Ozdogan, H.; Vanderschueren, S.; Marzan, K.; Kahlenberg, J. M.; Dekker, E.; De Benedetti, F.; Koné-Paut, I. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0291 TOFACITINIB FOR THE TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: RESULTS OF A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY. (2nd June 2020) Authors: Ruperto, N.; Synoverska, O.; Ting, T.; Abud-Mendoza, C.; Spindler, A.; Vyzhga, Y.; Marzan, K.; Keltsev, V.; Tirosh, I.; Imundo, L.; Jerath, R.; Kingsbury, D.; Sözeri, B.; Vora, S.; Prahalad, S.; Zholobova, E.; Butbul Aviel, Y.; Chasnyk, V.; Lerman, M.; Nanda, K. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0215 Long-Term Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 5-Year Follow-up of An Open-Label Trial. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Quartier, P.; Constantin, T.; Alexeeva, E.; Schneider, R.; Kone-Paut, I.; Schikler, K.; Marzan, K.; Wulffraat, N.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kuemmerle-Deschner, J.B.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0216 Safety and Effectiveness of Adalimumabmethotrexate for The Treatment of Polyarticular Juvenile Idiopathic Arthritis (PJIA): Strive Registry. (15th July 2016) Authors: Ruperto, N.; Lovell, D.J.; Wallace, C.; Toth, M.; Foeldvari, I.; Bohnsack, J.; Milojevic, D.; Rabinovich, E.; Kingsbury, D.; Marzan, K.; Quartier, P.; Minden, K.; Chalom, E.; Horneff, G.; Kuester, R.M.; Dare, J.; Heinrich, M.; Kupper, H.; Kalabic, J.; Martini, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial. (15th July 2016) Authors: Ruperto, N.; Brunner, H.I.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kuemmerle-Deschner, J.B.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Leon, K. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗